If the cells you would like to access are currently listed as unavailable
              or you are ordering from outside of Europe please get in touch via
              Contact@EBiSC.org.
          
    			DRICUi006-A
	
	ADANG10496CA	
        			        			iPSC line
                                    A CLIP contains information about a cell line including any
                                    specific third party obligations relating to, for example,
                                    licensing obligations or the donor consent which affect the
                                    use of the cell line.
                                
                                                        
                                    The EBiSC Access and Use Agreement must be completed along with an individual
                                    Cell Line Information Pack for each line. Complete the EAUA and send to Contact@EBiSC.org
                                    for countersignature. The EAUA must be fully signed before proceeding with your order.
                                
                                                    
                                A batch specific Certificate of Analysis will be available to
                                download once you receive your EBiSC iPSC line.
                            
                        General#
Cell Line | 
					|
| hPSCreg name | DRICUi006-A | 
| Alternative name(s) | 
									 
	ADANG10496CA	 
							 | 
						
| Cell line type | Human induced pluripotent stem cell (hiPSC) | 
| Similar lines | 
							 | 
					
| Notes | Further anonymized information about the donor including demographic and clinical data will be made available on the Dementia Platforms UK data portal: https://portal.dementiasplatform.uk/ | 
Provider | 
					|
| Depositor | UK Dementia Research Institute, Cardiff University (DRICU) | 
| Owner | UK Dementia Research Institute, Cardiff University (DRICU) | 
| Distributors | 
															 
									EBiSC																																																																																																																																																													 
														 | 
						
| Derivation country | United Kingdom | 
External Databases | 
						|
| hPSCreg | DRICUi006-A | 
| BioSamples | SAMEA10291413 | 
| Cellosaurus | CVCL_B3P4 | 
| Wikidata | Q110432785 | 
							    
							General Information | 
					|
| Publications | View all related publications on hPSCreg (1) | 
| This EBiSC line can be used for: | 
                                 Yes 
                                Research use: allowed 
                                Clinical use: no 
                                Commercial use: no 
                             | 
                        
Donor Information#
General Donor Information | 
					|
| Sex | male | 
| Age of donor (at collection) | 75-79 | 
| Ethnicity | Caucasian | 
Phenotype and Disease related information (Donor) | 
					|
| Diseases | A disease was diagnosed.
																	 | 
					
Karyotyping (Donor) | 
						|
| Has the donor karyotype been analysed? | 
								 Yes 								
																	
												Normal
											 
																				
																					
																															
											Karyotyping method:
											Molecular karyotyping by SNP array											
											 
																			http://  | 
						
Other Genotyping (Donor) | 
						|
| Is there genome-wide genotyping or functional data available? | 
								 Yes 								
																										
										SNP typing array										
										 
																								https://portal.dementiasplatform.uk/ipmar/cell-line-discovery-tool/  | 
						
External Databases (Donor) | 
						|
| BioSamples | SAMEA10563836 | 
hIPSC Derivation#
General | 
						|
| Source cell type | 
										
				
	
			 A thymocyte-derived lymphocyte of immunological importance that is long-lived (months to years) and is responsible for cell-mediated immunity. T lymphocyte cells form rosettes with sheep erythrocytes and, in the presence of transforming agents (mitogens), differentiate and divide. These cells have the characteristic T3 surface marker and may be further divided into subsets according to function, such as helper, cytotoxic, etc. 
	
			Synonyms 
		
  | 
							
| Source cell origin | 
										
				
	
			 A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood. 
	
			Synonyms 
		
  | 
							
| Age of donor (at collection) | 75-79 | 
Reprogramming method | 
						|
| Vector type | Non-integrating | 
| Vector | Sendai virus | 
| Genes | |
| Is reprogramming vector detectable? | 
										 No 									 | 
								
| Methods used | 
										 
	PCR	 
									 | 
								
| Notes on reprogramming vector detection | virus undetectable at Passage 9 | 
| Files and images showing reprogramming vector expressed or silenced | |
Vector free reprogramming | 
						|
Other | 
						|
| Derived under xeno-free conditions | 
								 No 							 | 
						
| Derived under GMP? | 
								 No 							 | 
						
| Available as clinical grade? | 
								 No 							 | 
						
Culture Conditions#
Latest released batch | 
                |
| Culture medium | mTeSR1 | 
| Passage method | EDTA | 
| Surface coating | Matrigel | 
| O2 concentration | 18 | 
| CO2 concentration | 5 | 
| Temperature | 37°C | 
					The following are the depositor culture conditions, they do not refer to any specific batch.
				
			
			| Surface coating | Matrigel/Geltrex | |||||||||||||||||||||
| Feeder cells | 
															 No 														 | 
						|||||||||||||||||||||
| Passage method | 
								Enzyme-free cell dissociation
								
																											 
											EDTA										 
																	
							 | 
						|||||||||||||||||||||
| O2 Concentration | 18 % | |||||||||||||||||||||
| CO2 Concentration | 5 % | |||||||||||||||||||||
| Medium | 
								Other medium:		 
			Base medium: Advanced DMEM/F12 (Gibco Thermo Fisher 12634010)			 
				
				Main protein source: Albumine Serum concentration: 0 % Supplements 
				
  | 
						|||||||||||||||||||||
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes  | 
					|||||||||||||||||||||
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | Yes  | 
					|||||||||||||||||||||
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes  | 
					
Characterisation#
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles | 
| TRA 1-60 | 
											 Yes 						                 | 
																                
						                |||||
| NANOG | 
											 Yes 						                 | 
																                
						                
Morphology pictures
IPMAR_DRICUi006A_Morphology.pdf
Morphology of DRICUi006A on day 2 -post thaw 
Differentiation Potency
In vitro directed differentiation
					| Marker | Expressed | 
| C-X-C Chemokine Receptor Type 4 | 
										 Yes 					                 | 
								
| SRY-box transcription factor 17 | 
										 Yes 					                 | 
								
Morphology
IPMAR_DRICUi006-A_Endoderm.pdf
IPMAR_DRICUi006-A_ICC_image for Endoderm
In vitro directed differentiation
					| Marker | Expressed | 
| C-X-C Chemokine Receptor Type 4 | 
										 Yes 					                 | 
								
| BRACHYURY | 
										 Yes 					                 | 
								
Morphology
IPMAR_DRICUi006-A_Mesoderm.pdf
IPMAR_DRICUi006A_ICC image_ Mesoderm
| Marker | Expressed | 
| Paired box 6 | 
										 Yes 					                 | 
								
| orthodenticle homeobox 2 | 
										 Yes 					                 | 
								
Morphology
IPMAR_DRICUi006-A_Ectoderm.pdf
IPMAR_DRICUi006A_ICC image_ectoderm markers 
Microbiology / Virus Screening | 
						|
| HIV 1 | Negative | 
| HIV 2 | Negative | 
| Hepatitis B | Negative | 
| Hepatitis C | Negative | 
| Mycoplasma | Negative | 
Sterility | 
						|
| Inoculation for microbiological growth | No Contaminants Detected | 
| Mycoplasma | Not Detected | 
| Viability | Viable post-cryopreservation | 
Genotyping#
Karyotyping (Cell Line) | 
					|
| Has the cell line karyotype been analysed? | 
								 Yes 								
																	
												7q34 deletion of 477 kilobases (chr7:142023396-142500409), 14q11.2 deletion of 810 kilobases (chr14:22193075-23002684). No other abnormalities >0.4 Mb.
											 
																				
																					
																															
											Passage number: 13											 
																													 | 
						
Other Genotyping (Cell Line) | 
					|